Efficacy and Safety of a First-in-Class Investigational Prescription Digital Therapeutic for Episodic Migraine (CT-132): Phase 3 Double-Blind, Randomized, Controlled Trial (P4-12.006)
Efficacy and Safety of a First-in-Class Investigational Prescription Digital Therapeutic for Episodic Migraine (CT-132): Phase 3 Double-Blind, Randomized, Controlled Trial (P4-12.006)
Timothy Peters-Strickland, Cassandra Snipes, Olya Besedina, Alexander Kuka et al.
Citations
3 citations
Journal
Neurology
Topics
Migraine and Headache Studies
Field-Weighted Citation Impact (FWCI)
4.41
article
Efficacy and Safety of a First-in-Class Investigational Prescription Digital Therapeutic for Episodic Migraine (CT-132): Phase 3 Double-Blind, Randomized, Controlled Trial (P4-12.006)
Timothy Peters-Strickland, Cassandra Snipes, Olya Besedina, Alexander Kuka, Stewart J. Tepper, Shaheen Emmanuel Lakhan, Laura Taraboanta, Mariya Petrova
article en
3 citations
Abstract
No abstract available for this paper.
Publication Tag
NeurologyVol. 104(7_Supplement_1)
Institutions
New England Institute for Neurology and Headache (US)